Publications scientifiques Archive - Centre de recherche du CHU de Québec-Université Laval

article Sadat Kiaei D, Caru M, Larouche V, Clini E, Pugalenthi Saravanan D, Lippé S, Théoret Y, Décarie JC, Tabori U, Hawkins C, Ellezam B, Ospina LH, Desjardins L, Métras MÉ and Sultan S, Cantin É and Routhier MÈ and Mailloux C, Bertrand MC, Estephan K, McKeown T, Vairy S, Legault G, Renzi S, Bouffet É and Ramaswamy V, Coltin H, Lafay-Cousin L, Hukin J, Alves M, Rent T, Erker C, Jabado N, Dehaes M, Perreault S

TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas

Neuro Oncol 28 (9), 2026.

DOI PUBMED

article Crowell C, Mankuzhy NP, Bennett J, Bandopadhayay P, Sturm D, Green AL, Gupta T, Chatterjee A, Epari S, Chinnaswamy G, Prasad M, Patel SH, MacNeil M, Vanan MI, Larouche V, Renzi S, Jones J, Perreault S, Mata-Mbemba D, Sangatsuda Y, Yoshimoto K, Lin E, Feddersen C, Cruz O, Pavon-Mengual M, Vizzini O, Zápotocký M, Popovacki A, Klawinski D, Hansford JR, Schlosser MP, Omene E, Alexander KL, Satgunaseelan L, Williams A, Yao K, Ronsley R, Cheng S, Ludlow L, Eisenstat D, Khuong-Quang DA, Tabouret E, André N, Matheson K, Chan A, Lim-Fat MJ, Lapointe S, Cayrol R, Coleman C, Juretic N, McThenia S, Khan S, Wright-Nadkarni M, Salloum R, Galvin RT, Sener U, Hawkins C, Imber BS, Karajannis MA, Jones DTW, Ligon KL, Jabado N, Erker C

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional Study

Clin Cancer Res 32 (11), 2026.

DOI PUBMED

article Silverman J, Mégalli M, Giguère E, Elbaz S, Letourneau M, Achim C, Hawkins C, Legallou W, Giannakouros P, Perreault S, Legault G, Bouffet E, Jabado N, Coltin H, Crevier L, Renzi S

Adjuvant Etoposide for Very High-Risk PFA Ependymoma: A Case Report

J Pediatr Hematol Oncol 47 (6), 2025.

DOI PUBMED

article Audet-Walsh É and Galey L, Renzi S, Morin N, Hussein SMI, Richer M, Huot MÉ

Combining anti-metabolic treatments with the repurposing of eribulin for glioblastoma: a clinical opportunity

Transl Cancer Res 14 (11), 2025.

DOI PUBMED

article Allain L, Elbaz S, Sathyakumar S, Le Gallou W, Coleman C, Coltin H, Eugène D, Gupta A, Lava SAG, Renzi S

Significant Response to Denosumab Yet with Severe Rebound Hypercalcemia in a 9-Year-Old Boy with Aneurysmal Bone Cyst: A Case Report

Children (Basel) 12 (11), 2025.

DOI PUBMED

article Apfelbaum AA, Morin E, Sturm D, Ayoub G, DiGiacomo J, Bahadur S, Chandarana B, Power PC, Cusick MM, Novikov D, Prabhakar P, Jones RE, Vogelzang J, Bossi CC, Malinowski S, Woodward LM, Jones TA, Jeang J, Lamson SW, Collins J, Cai KY, Jones JS, Oh S, Jeon H, Wang J, Cameron A, Rechter P, De Leon A, Murugesan K, Montesion M, Albacker LA, Ramkissoon SH, van Tilburg CM, Hardin EC, Sievers P, Sahm F, Yeo KK, Rosenberg T, Chi SN, Wright KD, Hébert S, Peck S, Picca A, Larouche V, Renzi S, Buhrlage SJ, Bale TA, Smith AA, Touat M, Jabado N, Fischer ES, Eck MJ, Baird L, Witt O, Kleinman CL, Nguyen QD, Sheer D, Alexandrescu S, Jones DTW, Ligon KL, Bandopadhayay P

A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas

Nat Commun 16 (1), 2025.

DOI PUBMED

article Roberge X, Silva Baticam N, Vairy S, Dubé M, Kleiber N, Tran TH, Crevier L, Renzi S

Prenatal diagnosis and conservative management of a congenital cavernous sinus infantile hemangioma: illustrative case

J Neurosurg Case Lessons 10 (7), 2025.

DOI PUBMED

article Coltin H, Trudeau-Ferrin O, Perreault S, Lafay-Cousin L, Tsang DS, Renzi S, Larouche V, Erker C, Hukin J, Barber R, Nathan PC, Huang A, Bouffet E, Ramaswamy V

Severe Hearing Loss in Children With Central Nervous System Tumors: A Population-Based Cancer in Young People in Canada (CYP-C) Report

Pediatr Blood Cancer 72 (11), 2025.

DOI PUBMED

article Apfelbaum AA, Morin E, Sturm D, Ayoub G, DiGiacomo J, Bahadur S, Chandarana B, Power PC, Cusick MM, Novikov D, Prabhakar P, Jones RE, Vogelzang J, Bossi CC, Malinowski S, Woodward LM, Jones TA, Jeang J, Lamson SW, Collins J, Cai KY, Jones JS, Oh S, Jeon H, Wang J, Cameron A, Rechter P, De Leon A, Murugesan K, Montesion M, Albacker LA, Ramkissoon SH, van Tilburg CM, Hardin EC, Sievers P, Sahm F, Yeo KK, Rosenberg T, Chi SN, Wright KD, Hébert S, Peck S, Picca A, Larouche V, Renzi S, Buhrlage SJ, Bale TA, Smith AA, Touat M, Jabado N, Fischer ES, Eck MJ, Baird L, Witt O, Kleinman CL, Nguyen QD, Sheer D, Alexandrescu S, Jones DTW, Ligon KL, Bandopadhayay P

Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas

Nat Commun 16 (1), 2025.

DOI PUBMED

article Dion B, Sathyakumar S, Silverman J, Coltin H, Legault G, Perreault S, D'Astous M, Lessard N, Saikali S, Dion N, Lava S, Bouffet E, Jabado N, Renzi S

Sustained response to trametinib in an adult patient with neurofibromatosis type 1 and high-grade glioma

Childs Nerv Syst 41 (1), 2025.

DOI PUBMED

article Silva Baticam N, Roberge X, Laliberté I, Gauquelin L, Liu A, Hawkins C, Dubé M, Brisson MC, Bergeron Gravel S, Eugène D, Jabado N, Vairy S, Crevier L, Renzi S

Ifosfamide-Related Optic Nerve Toxicity: Case Description and Review of the Literature

Pediatr Blood Cancer 72 (8), 2025.

DOI PUBMED

article Reeves-Breton L, Allain L, Sathyakumar S, Boyer E, Crevier L, Perreault S, Richer M, Bourget C, Giannakouros P, LeGallou W, Faury D, Laflamme J, Hawkins C, Bouffet E, Jabado N, Coltin H, Renzi S

Disseminated DIG-DIA With a Rare FMR1-RAF1 Fusion With Good Response to Targeted Therapy

Pediatr Blood Cancer 72 (2), 2025.

DOI PUBMED